Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.

Pfaller, M A; Messer, S A; Boyken, L; Tendolkar, S; Hollis, R J; Diekema, D J

Pfaller, M A; Messer, S A; Boyken, L; Tendolkar, S; Hollis, R J; Diekema, D J.

Affiliation

Pfaller MA; Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA. michael-pfaller@uiowa.edu

J Clin Microbiol ; 46(2): 551-9, 2008 Feb.

Article in En | MEDLINE | ID: mdl-18094129

Subject(s)

Antifungal Agents/pharmacology; Candida/drug effects; Fluconazole/pharmacology; Microbial Sensitivity Tests/methods; Pyrimidines/pharmacology; Triazoles/pharmacology; Biomarkers; Candida/isolation & purification; Candidiasis/microbiology; Humans; Regression Analysis; Voriconazole

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Triazoles / Candida / Microbial Sensitivity Tests / Fluconazole / Antifungal Agents Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Clin Microbiol Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google